How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study

  title={How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study},
  author={Bruce A. Griffin},
  journal={Current Opinion in Lipidology},
  • B. Griffin
  • Published 1 February 2008
  • Medicine
  • Current Opinion in Lipidology
Purpose of review There has been much debate over the practical utility of the dietary ratio of n-6 to n-3 polyunsaturated fatty acids in optimizing the benefits of n-3 fatty acids (C18–C22) on cardiovascular health. This review examines the supporting evidence from the OPTILIP study within the context of the emerging consensus on the value of this dietary metric. Recent findings The question of whether the ratio of n-6/n-3 polyunsaturated fatty acids or total amounts of dietary polyunsaturated… 
Recent evidence on omega 6 fatty acids and cardiovascular risk
Omega 6 fatty acids appear to be extremely helpful in CHD risk reduction and a hypothetical reduction of omega 6 intake by the population at large would actually increaseCHD risk, but based on the most recent studies this is most probably not the case.
A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter?
The role of n-6 PUFAs on human health needs to be better assessed in order to clearly identify which compound exerts beneficial/harmful effects, and a number of limitations when considering the ratio between these two families of PUF as have risen.
The Role of n-3 Fatty Acids in Cardiometabolic Risk
It is indicated that adequate n-3 LCPUFA intakes may be instrumental in maintaining good health throughout life, including in the optimisation of cardiovascular health, as well as improving compliance through the use of newly emerging technologies such as metabolomics.
Prevention of Cardiovascular Disease by Dietary n-3 Fatty Acid
The available scientific evidence suggests that Omega-3 polyunsaturated fatty acids supplementation and clinical use ranging from 0.4 to 7g/day can provide tangible benefits, however, further studies are required to determine optimal dosing and the relative ratio of docosahexaenoic acid and eicosapentaenoic acids that provides maximal cardio-protection and treatment of CVD.
Effects of n-3 Polyunsaturated Fatty Acids (ω-3) Supplementation on Some Cardiovascular Risk Factors with a Ketogenic Mediterranean Diet
Background: the ketogenic diet (KD) has become a widely used nutritional approach for weight loss. Some of the KD’s positive effects on metabolism and cardiovascular risk factors are similar to those
Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: Nutritional recommendations
Examination of changes in dietary patterns that have led to the present reduction in the consumption of ω-3 essential fatty acids is examined, to study the importance of theπ�-6/ω-3 balance in maintaining good health and the established recommendations for preventing a poor intake.
Effect of ALA-Enriched Food Supply on Cardiovascular Risk Factors in Males
It is demonstrated that enrichment of commonly eaten food items with n-3 fatty acids provides the opportunity to increase the n- 3 fatty acid intake and to decrease then-6/n-3 ratio which results in a decreasing diastolic blood pressure and an increase of HDL-cholesterol (in non-smokers).
Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study.
High intakes (≥3 servings/wk) of fish relative to lower intakes were associated with maintenance of femoral neck BMD in men and women and in women and fish consumption may protect against bone loss.


Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study.
The reduction in plasma triacylglycerol after an increased intake of n-3 long-chain PUFAs results in favorable changes in LDL size, and decreasing the n-6:n-3 does not influence insulin sensitivity or lipase activities in older subjects.
n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.
Evidence suggests that increased consumption of n-3 FAs from fish or fish-oil supplements, but not of alpha-linolenic acid, reduces the rates of all-cause mortality, cardiac and sudden death, and possibly stroke.
Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity.
With caveats inherent for ecologic, nutrient disappearance analyses, a healthy dietary allowance for n-3 LCFAs for current US diets was estimated at 3.5 g/d for a 2000-kcal diet, which can likely be reduced to one-tenth of that amount by consuming fewer n-6 fats.
Dietary n-3 fatty acid intake and risk of sudden death and coronary artery disease
  • C. Albert
  • Medicine
    Current treatment options in cardiovascular medicine
  • 2007
Opinion statementBased upon the data from observational epidemiologic studies and randomized clinical trials that are summarized in this article, as well as plausible mechanisms for benefit, the
Omega-3 Fatty Acids and Cardiovascular Disease: New Recommendations From the American Heart Association
Large-scale epidemiologic studies suggest that people at risk for coronary heart disease (CHD) benefit from consuming omega-3 fatty acids from plants and marine sources.
α-Linolenic acid metabolism in adult humans: the effects of gender and age on conversion to longer-chain polyunsaturated fatty acids
Stable isotope tracer studies indicate that conversion of LNA to eicosapentaenoic acid (EPA) occurs but is limited in men and that further transformation to docosahexaenoic Acid (DHA) is very low, and LNA appears to be a limited source of longer-chain n-3 PUFA in man.
n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored.
A recent study suggests that long-chain n-3 PUFAs might also act to stabilize advanced atherosclerotic plaques, perhaps through their anti-inflammatory effects.